These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23894239)

  • 1. Effect of the refrigerator storage time on the potency of botox for human extensor digitorum brevis muscle paralysis.
    Park MY; Ahn KY
    J Clin Neurol; 2013 Jul; 9(3):157-64. PubMed ID: 23894239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use.
    Sloop RR; Cole BA; Escutin RO
    Neurology; 1997 Jan; 48(1):249-53. PubMed ID: 9008526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-week-old Botox.
    Yang GC; Chiu RJ; Gillman GS
    Arch Facial Plast Surg; 2008; 10(4):273-9. PubMed ID: 18645097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced potency after refrigerated storage of botulitum toxin A: human extensor digitorum brevis muscle study.
    Paik NJ; Seo K; Eun HC
    Mov Disord; 2006 Oct; 21(10):1759-63. PubMed ID: 16856132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystalline preparation of botulinum toxin type A (Botox): degradation in potency with storage.
    Gartlan MG; Hoffman HT
    Otolaryngol Head Neck Surg; 1993 Feb; 108(2):135-40. PubMed ID: 8441537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of reconstituted and stored botulinum toxin type A: an electrophysiologic and visual study in the auricular muscle of the rabbit.
    Jabor MA; Kaushik R; Shayani P; Ruiz-Razura A; Smith BK; Morimoto KW; Cohen BE
    Plast Reconstr Surg; 2003 Jun; 111(7):2419-26; discussion 2427-31. PubMed ID: 12794491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human response to botulinum toxin injection: type B compared with type A.
    Sloop RR; Cole BA; Escutin RO
    Neurology; 1997 Jul; 49(1):189-94. PubMed ID: 9222189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of two botulinum toxin type A complexes (Dysport and Botox) in volunteers: a double-blind, randomized, dose-ranging study.
    Wohlfarth K; Schwandt I; Wegner F; Jürgens T; Gelbrich G; Wagner A; Bogdahn U; Schulte-Mattler W
    J Neurol; 2008 Dec; 255(12):1932-9. PubMed ID: 18854916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report.
    Hefter H; Beek J; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34203875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers.
    Jost WH; Kohl A; Brinkmann S; Comes G
    J Neural Transm (Vienna); 2005 Jul; 112(7):905-13. PubMed ID: 15526142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
    Hui JI; Lee WW
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation.
    Alam M; Yoo SS; Wrone DA; White LE; Kim JY
    J Am Acad Dermatol; 2006 Aug; 55(2):272-5. PubMed ID: 16844511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foam during reconstitution does not affect the potency of botulinum toxin type A.
    Trindade De Almeida AR; Kadunc BV; Di Chiacchio N; Neto DR
    Dermatol Surg; 2003 May; 29(5):530-1; discussion 532. PubMed ID: 12752523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of bacterial or fungal growth in vials of reconstituted botulinum toxin type A after storage.
    Osaki T; Osaki MH; Osaki TH; Sant'Anna AE; Yu MC; Hofling-Lima AL
    Aesthet Surg J; 2015 Feb; 35(2):189-93. PubMed ID: 25717119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines.
    Lizarralde M; Gutiérrez SH; Venegas A
    Dermatol Surg; 2007 Nov; 33(11):1328-33; discussion 1333. PubMed ID: 17958584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve stimulation boosts botulinum toxin action in spasticity.
    Frasson E; Priori A; Ruzzante B; Didonè G; Bertolasi L
    Mov Disord; 2005 May; 20(5):624-9. PubMed ID: 15726575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of extensor digitorum brevis thickness in healthy subjects: A comparative analysis of nerve conduction studies and ultrasound scans.
    Seok JI; Walker FO; Kwak SG
    Clin Neurophysiol; 2016 Feb; 127(2):1664-1668. PubMed ID: 26315368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensor digitorum brevis test and resistance to botulinum toxin type A.
    Gordon PH; Gooch CL; Greene PE
    Muscle Nerve; 2002 Dec; 26(6):828-31. PubMed ID: 12451609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of Split-Leg Signs in Amyotrophic Lateral Sclerosis: Differential Involvement of the Extensor Digitorum Brevis and Abductor Hallucis Muscles.
    Wang ZL; Cui L; Liu M; Zhang K; Liu S; Ding Q; Hu Y
    Front Neurol; 2019; 10():565. PubMed ID: 31191446
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A.
    Sloop RR; Escutin RO; Matus JA; Cole BA; Peterson GW
    Neurology; 1996 May; 46(5):1382-6. PubMed ID: 8628486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.